Nuredis, Inc.

About Nuredis, Inc.

Nuredis, a pre-clinical stage company, is developing small molecule therapies to treat a group of inherited neurodegenerative and neuromuscular diseases caused by the expansion of normally-short nucleotide repeats sequences in human genes, with Huntington's Disease as the first indication.

YEAR FOUNDED:

2016

LEADERSHIP:

Founder: Stanley N. Cohen

CEO: Julie Anne Smith